Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Cell Signal. 2017 Aug 9;39:95–107. doi: 10.1016/j.cellsig.2017.08.002

Table 2. GPCRs in B cell lymphoma studies.

GPCRs that have been investigated in B cell lymphoma are shown corresponding to the specific diseases in which each receptor has been studied.

GPCR B-ALL CLL/SLL MCL BL FL DLBCL MZL/MALT LPL/WM HCL
ACKR3 [13] [80] [173] [173]
ADGRV1 [183]
ADORA2A [55]
ADORA2B [55]
ADRB2 [52][53] [116] [161]
CALCR [56]
CCKBR [186]
CCR1 [2][14] [14][72] [14][72][116] [2][14][116] [14][72][116][148] [14][172][173] [14][72][172][173] [14][193] [14][72]
CCR2 [2] [72] [72] [2] [72][151] [72] [193] [72]
CCR3 [2] [72] [72][116] [2][116] [72][116][150] [72] [193] [72]
CCR4 [2][12] [12] [2] [175][180–182] [172][175] [193]
CCR5 [2][3][10] [3][10][72] [10][72] [2] [3][10][72] [172][173] [72][172][173] [193] [3][10][72]
CCR6 [2][3][10] [3][10][61][72][93][102] [10][72][102][115][116][118] [2][116] [3][10][72][102][116] [172][178] [72][102][135][172] [193] [3][10][72]
CCR7 [2][3][12][94] [3][12][43][46][61][71][76][94][96–101] [71][116][118] [2][116] [3][71][116][118][142] [118][161][166][172][173][178] [71][118][172][173] [193] [3][71][206]
CCR8 [136][172][173] [172][173] [193]
CCR9 [12] [12] [149] [149][173][178] [173]
CCR10 [172] [172]
CCRL2 [99]
CELSR1 [183]
CELSR2 [183]
CELSR3 [183]
CNR1 [51] [50][51] [51][107–116] [51] [51][103] [51] [51]
CNR2 [51] [50][51] [51][107–116] [51] [51][135] [51][161–162] [51]
CX3CR1 [103–105] [103] [103][150] [103] [103]
CXCR1 [2] [72] [72] [72] [172] [72][172] [193] [72]
CXCR2 [2] [72][106] [72] [72] [72] [193] [72]
CXCR3 [2][3][4][12] [3][4][12][66][68–70][72][76] [4][68][72] [4] [3][4][72] [4][172][173][175] [4][72][172][173][175–177][189–191] [193] [3][4][68][72]
CXCR4 [2][3][5–11] [3][10][46][71–89][91][92][100][125][192][202] [10][71][72][102][118] [2][123–126][132] [3][10][71][72][118][123][131–133][139][144–147][151][202] [118][132][139][163–173][178][202] [71][72][118][139][172][173][183][192] [192–204] [3][10][71][72]
CXCR5 [2][3][4][10][12] [3][4][10][12][71][72][90–95][137] [4][10][71][72][90][115][116][118][137] [2][4][116][122] [3][4][10][71][72][90][116][118][136–142] [118][136][139][141][166][172][173][178] [4][71][72][118][137][172][173] [4][193] [3][4][10][71][72]
CXCR6 [12] [12] [172][173] [173]
CYSLT1 [57][179] [179] [179] [179] [179] [179]
EDNRA [58]
F2R [39] [39]
FZD3 [65][66]
FZD6 [63][64]
GPER1 [11] [121] [121] [121]
GPR34 [38] [184] [184][185]
GPR65 [59]
GPR82 [185]
GPR132 [32][33]
GPR183 [103] [161]
LPAR1 [47–49]
LPAR3 [47]
LPAR5 [47]
LTB4R [60]
MRGPRF [120]
NTSR1 [62]
NTSR2 [62]
P2RY8 [1][15–31] [130–132][134]
P2RY11 [55] [115][116]
PTGER1 [37] [127]
PTGER2 [34–37] [127]
PTGER3 [37] [127]
PTGER4 [37] [127][128] [103]
S1PR1 [40][117] [40][43–46][117] [117–119] [117] [117][118][142] [117][118][156–161] [117][118] [117]
S1PR2 [40] [40][43] [118] [118][131][132] [118][136][152–155] [118]
S1PR3 [118] [118] [118] [118]
S1PR4 [40] [40]
SSTR1–SSTR5 [187][188]
TAAR1 [129] [129] [129] [129]
TACR1 [41] [41]
TBXA2R [61]
XCR1 [172–174] [172][173]